Albiglutide

Eperzan

BrazilCancelledAuthorised 23 Nov 2015

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

EperzanCanada · 30 MG / 0.5 ML · Powder For Solution · Glaxosmithkline INCSame brand
EperzanCanada · 50 MG / 0.5 ML · Powder For Solution · Glaxosmithkline INCSame brand
EperzanEuropean Union · GlaxoSmithKline Trading Services LimitedSame brand
EPERZAN 30 mg Powder and Solvent For Solution For InjectionSaudi Arabia · Vetter Pharma-Fertigung GMBH & Co. KGSame brand
EPERZAN 50 mg Powder and Solvent For Solution For InjectionSaudi Arabia · Vetter Pharma-Fertigung GMBH & Co. KGSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Albiglutide

Eperzan

BrazilCancelledAuthorised 23 Nov 2015

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tanzeum

United States · 30MG · injectable · Glaxosmithkline LLC

TanzeumUnited States · 50MG · For Injection · GlaxoSmithKline LLC

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Albiglutide
Register: Brazil (Anvisa)
Status: Cancelled
Status in the register: Inativo
Authorised: 23 Nov 2015
Registration: 101070317
Marketing authorisation holder: Glaxosmithkline Brasil Ltda
Procedure: Registered